Hem › Myeloproliferativa neoplasmer › Idaho › Boise
Kliniska studier för Myeloproliferativa neoplasmer i Boise, ID
4 studier för Myeloproliferativa neoplasmer söker deltagare vid platser i och runt Boise (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RekryterarFas 2
- Saint Alphonsus Cancer Care Center-Boise, Boise
- Saint Luke's Cancer Institute - Boise, Boise
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RekryterarFas 2
- Saint Alphonsus Cancer Care Center-Boise, Boise
- Saint Luke's Cancer Institute - Boise, Boise
Project: Every Child for Younger Patients With Cancer
RekryterarObservationsstudie
- Saint Luke's Cancer Institute - Boise, Boise
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekryterarObservationsstudie
- Massive Bio SYNERGY-AI site, Boise
Myeloproliferativa neoplasmer-studier i andra städer
- Houston, TX16 studier
- New York City, NY15 studier
- Boston, MA14 studier
- Milwaukee, WI10 studier
- Miami, FL10 studier
- Durham, NC9 studier
- Baldwin Park, CA9 studier
- Seattle, WA9 studier
- Chicago, IL9 studier
- Portland, OR8 studier
- Cleveland, OH8 studier
- Atlanta, GA8 studier
Andra studier i Boise
- Icke-småcellig lungcancer14 studier
- Lungcancer11 studier
- Akut myeloid leukemi8 studier
- Prostatacancer8 studier
- Tjocktarmscancer7 studier
- Kolorektal cancer6 studier
- Andnödssyndrom6 studier
- Bröstcancer6 studier
- Melanom6 studier
- Burkitts lymfom5 studier
- Bukspottkörtelcancer4 studier
- Myelodysplastiska syndrom4 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.